Company name
2022Founder
Adam Goulburn co-founds Dimension, where he invests across biology, healthcare, and computing. Previously, he invested at Lux Capital and helped start biotechnology companies including Kallyope; before venture investing, he researched neuroscience at Weill Cornell Medical College.
Co-Founder
Independent Director
Served on the listed company’s board and nominating and corporate governance committee.
Founding CEO
Helped establish the biotechnology company that later became part of Aera Therapeutics.
Founding CEO
Helped establish a biotechnology company studying the gut-brain axis.
Postdoctoral Fellow, Neuroscience
Researched regenerative stem-cell medicine and brain disorders.
PhD (2010)
Bachelor of Commerce / Bachelor of Science (2005)
PhD
Cosign details are not available yet.
More profile details are not available yet.